Is genAI a Gateway Drug to Runaway Costs?

GenAI surge boosts productivity but raises security concerns

Generative AI use in businesses surged 890% in 2024, boosting productivity but doubling security incidents and raising serious data risks.

Is genAI a gateway drug to runaway costs?

As much as enterprise IT executives complain today about the sky-high cost of generative AI (genAI) model access, some fear those costs will skyrocket in the next couple of years.  Why? The theory is that the large language model (LLM) makers will wait until their code has become such an integral part of the enterprise environment that unraveling it and starting over with a different model will be cost-prohibitive. Once that happens, genAI firms…